Use of proton magnetic resonance spectroscopy of the brain to differentiate gliomatosis cerebri from low-grade glioma (original) (raw)
Bendszus M, , Warmuth-Metz M, & Klein R, et al: MR spectroscopy in GC. AJNR 21:375–380, 2000 Bendszus M, Warmuth-Metz M, Klein R, et al: MR spectroscopy in GC. **AJNR 21:**375–380, 2000
PubMed Bendszus M, Warmuth-Metz M, Klein R, et al: MR spectroscopy in GC. AJNR 21: 375– 380, 2000 Bendszus M, Warmuth-Metz M, Klein R, et al: MR spectroscopy in GC. AJNR 21:375–380, 2000 )| false
Brand A, , Richter-Landsberg C, & Leibfritz D: Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289–298, 1993 Brand A, Richter-Landsberg C, Leibfritz D: Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. **Dev Neurosci 15:**289–298, 1993
PubMed Brand A, Richter-Landsberg C, Leibfritz D: Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15: 289– 298, 1993 Brand A, Richter-Landsberg C, Leibfritz D: Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289–298, 1993 10.1159/000111347 )| false
Cairncross G, , Macdonald D, & Ludwin S, et al: Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:2013–2021, 1994 Cairncross G, Macdonald D, Ludwin S, et al: Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. **J Clin Oncol 12:**2013–2021, 1994
PubMed Cairncross G, Macdonald D, Ludwin S, et al: Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12: 2013– 2021, 1994 Cairncross G, Macdonald D, Ludwin S, et al: Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 12:2013–2021, 1994 10.1200/JCO.1994.12.10.2013 )| false
Castillo M, , Smith JK, & Kwock L: Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR 21:1645–1649, 2000 Castillo M, Smith JK, Kwock L: Correlation of myo-inositol levels and grading of cerebral astrocytomas. **AJNR 21:**1645–1649, 2000
PubMed Castillo M, Smith JK, Kwock L: Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR 21: 1645– 1649, 2000 Castillo M, Smith JK, Kwock L: Correlation of myo-inositol levels and grading of cerebral astrocytomas. AJNR 21:1645–1649, 2000 )| false
Cheng LL, , Chang IW, & Louis DN, et al: Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 58:1825–1832, 1998 Cheng LL, Chang IW, Louis DN, et al: Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. **Cancer Res 58:**1825–1832, 1998
PubMed Cheng LL, Chang IW, Louis DN, et al: Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 58: 1825– 1832, 1998 Cheng LL, Chang IW, Louis DN, et al: Correlation of high-resolution magic angle spinning proton magnetic resonance spectroscopy with histopathology of intact human brain tumor specimens. Cancer Res 58:1825–1832, 1998 )| false
Confort-Gouny S, , Vion-Dury J, & Nicoli F, et al: A multiparametric data analysis showing the potential of localized proton MR spectroscopy in the brain in the metabolic characterization of neurological diseases. J Neurol Sci 118:123–133, 1993 Confort-Gouny S, Vion-Dury J, Nicoli F, et al: A multiparametric data analysis showing the potential of localized proton MR spectroscopy in the brain in the metabolic characterization of neurological diseases. **J Neurol Sci 118:**123–133, 1993
PubMed Confort-Gouny S, Vion-Dury J, Nicoli F, et al: A multiparametric data analysis showing the potential of localized proton MR spectroscopy in the brain in the metabolic characterization of neurological diseases. J Neurol Sci 118: 123– 133, 1993 Confort-Gouny S, Vion-Dury J, Nicoli F, et al: A multiparametric data analysis showing the potential of localized proton MR spectroscopy in the brain in the metabolic characterization of neurological diseases. J Neurol Sci 118:123–133, 1993 10.1016/0022-510X(93)90101-4 )| false
Couch JR, & Weiss SA: Gliomatosis cerebri. Report of four cases and review of the literature. Neurology 24:504–511, 1974 Couch JR, Weiss SA: Gliomatosis cerebri. Report of four cases and review of the literature. **Neurology 24:**504–511, 1974
PubMed Couch JR, Weiss SA: Gliomatosis cerebri. Report of four cases and review of the literature. Neurology 24: 504– 511, 1974 Couch JR, Weiss SA: Gliomatosis cerebri. Report of four cases and review of the literature. Neurology 24:504–511, 1974 10.1212/WNL.24.6.504 )| false
del Carpio-O'Donovan R, , Korah I, & Salazar A, et al: Gliomatosis cerebri. Radiology 198:831–835, 1996 del Carpio-O'Donovan R, Korah I, Salazar A, et al: Gliomatosis cerebri. **Radiology 198:**831–835, 1996
PubMed del Carpio-O'Donovan R, Korah I, Salazar A, et al: Gliomatosis cerebri. Radiology 198: 831– 835, 1996 del Carpio-O'Donovan R, Korah I, Salazar A, et al: Gliomatosis cerebri. Radiology 198:831–835, 1996 10.1148/radiology.198.3.8628879 )| false
Frahm J, , Bruhn H, & Gyngell ML, et al: Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med 9:79–93, 1989 Frahm J, Bruhn H, Gyngell ML, et al: Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. **Magn Reson Med 9:**79–93, 1989
Galanaud D, , Le Fur Y, & Nicoli F, et al: Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging. MAGMA 13:127–133, 2001 Galanaud D, Le Fur Y, Nicoli F, et al: Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging. **MAGMA 13:**127–133, 2001
PubMed Galanaud D, Le Fur Y, Nicoli F, et al: Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging. MAGMA 13: 127– 133, 2001 Galanaud D, Le Fur Y, Nicoli F, et al: Regional metabolite levels of the normal posterior fossa studied by proton chemical shift imaging. MAGMA 13:127–133, 2001 10.1007/BF02668161 )| false
Kinoshita Y, & Yokota A: Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 10:2–12, 1997 Kinoshita Y, Yokota A: Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. **NMR Biomed 10:**2–12, 1997
PubMed Kinoshita Y, Yokota A: Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 10: 2– 12, 1997 Kinoshita Y, Yokota A: Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy. NMR Biomed 10:2–12, 1997 10.1002/(SICI)1099-1492(199701)10:1<2::AID-NBM442>3.0.CO;2-N )| false
Lev MH: Gliomatosis cerebri has normal relative blood volume:really?! Who cares? Should you? AJNR 23:345–346, 2002 Lev MH: Gliomatosis cerebri has normal relative blood volume:really?! Who cares? Should you? **AJNR 23:**345–346, 2002
PubMed Lev MH: Gliomatosis cerebri has normal relative blood volume:really?! Who cares? Should you? AJNR 23: 345– 346, 2002 Lev MH: Gliomatosis cerebri has normal relative blood volume:really?! Who cares? Should you? AJNR 23:345–346, 2002 )| false
Mader I, , Roser W, & Hagberg G, et al: Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. MAGMA 4:139–150, 1996 Mader I, Roser W, Hagberg G, et al: Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. **MAGMA 4:**139–150, 1996
PubMed Mader I, Roser W, Hagberg G, et al: Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. MAGMA 4: 139– 150, 1996 Mader I, Roser W, Hagberg G, et al: Proton chemical shift imaging, metabolic maps, and single voxel spectroscopy of glial brain tumors. MAGMA 4:139–150, 1996 10.1007/BF01772521 )| false
Michaelis T, , Merboldt KD, & Hänicke W, et al: On the identification of cerebral metabolites in localized 1H NMR spectra of the human brain in vivo. NMR Biomed 4:90–98, 1991 Michaelis T, Merboldt KD, Hänicke W, et al: On the identification of cerebral metabolites in localized 1H NMR spectra of the human brain in vivo. **NMR Biomed 4:**90–98, 1991
PubMed Michaelis T, Merboldt KD, Hänicke W, et al: On the identification of cerebral metabolites in localized 1H NMR spectra of the human brain in vivo. NMR Biomed 4: 90– 98, 1991 Michaelis T, Merboldt KD, Hänicke W, et al: On the identification of cerebral metabolites in localized 1H NMR spectra of the human brain in vivo. NMR Biomed 4:90–98, 1991 10.1002/nbm.1940040211 )| false
Negendank WG, , Sauter R, & Brown TR, et al: Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84:449–458, 1996 Negendank WG, Sauter R, Brown TR, et al: Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. **J Neurosurg 84:**449–458, 1996
PubMed Negendank WG, Sauter R, Brown TR, et al: Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84: 449– 458, 1996 Negendank WG, Sauter R, Brown TR, et al: Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg 84:449–458, 1996 10.3171/jns.1996.84.3.0449 )| false
Peretti-Viton P, , Brunel H, & Chinot O, et al: Historical and MR correlations in gliomatosis cerebri. J Neurooncol 59:249–259, 2002 Peretti-Viton P, Brunel H, Chinot O, et al: Historical and MR correlations in gliomatosis cerebri. **J Neurooncol 59:**249–259, 2002
Salvan AM, , Vion-Dury J, & Confort-Gouny S, et al: Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times. Invest Radiol 32:485–495, 1997 Salvan AM, Vion-Dury J, Confort-Gouny S, et al: Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times. **Invest Radiol 32:**485–495, 1997
PubMed Salvan AM, Vion-Dury J, Confort-Gouny S, et al: Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times. Invest Radiol 32: 485– 495, 1997 Salvan AM, Vion-Dury J, Confort-Gouny S, et al: Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times. Invest Radiol 32:485–495, 1997 10.1097/00004424-199708000-00008 )| false
Shin YM, , Chang KH, & Han MH, et al: Gliomatosis cerebri: comparison of MR and CT features. AJR 161:859–862, 1993 Shin YM, Chang KH, Han MH, et al: Gliomatosis cerebri: comparison of MR and CT features. **AJR 161:**859–862, 1993
Wilson NW, , Symon L, & Lantos PL: Gliomatosis cerebri: report of a case presenting as a focal cerebral mass. J Neurol 234:445–447, 1987 Wilson NW, Symon L, Lantos PL: Gliomatosis cerebri: report of a case presenting as a focal cerebral mass. **J Neurol 234:**445–447, 1987
PubMed Wilson NW, Symon L, Lantos PL: Gliomatosis cerebri: report of a case presenting as a focal cerebral mass. J Neurol 234: 445– 447, 1987 Wilson NW, Symon L, Lantos PL: Gliomatosis cerebri: report of a case presenting as a focal cerebral mass. J Neurol 234:445–447, 1987 10.1007/BF00314097 )| false
Yang S, , Wetzel S, & Law M, et al: Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri. AJNR 23:350–355, 2002 Yang S, Wetzel S, Law M, et al: Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri. **AJNR 23:**350–355, 2002
PubMed Yang S, Wetzel S, Law M, et al: Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri. AJNR 23: 350– 355, 2002 Yang S, Wetzel S, Law M, et al: Dynamic contrast-enhanced T2*-weighted MR imaging of gliomatosis cerebri. AJNR 23:350–355, 2002 )| false
Ziegler A, , von Kienlin M, & Decorps M, et al: High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. Cancer Res 61:5595–5600, 2001 Ziegler A, von Kienlin M, Decorps M, et al: High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. **Cancer Res 61:**5595–5600, 2001
PubMed Ziegler A, von Kienlin M, Decorps M, et al: High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. Cancer Res 61: 5595– 5600, 2001 Ziegler A, von Kienlin M, Decorps M, et al: High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. Cancer Res 61:5595–5600, 2001 )| false